Actively Recruiting
Led by King Saud University · Updated on 2024-10-29
125
Participants Needed
1
Research Sites
17 weeks
Total Duration
Researchers are evaluating Arabic patient-reported outcome measure (PROM) tools for people with head and neck cancer undergoing radiotherapy. These tools have not been cross-culturally validated in Arabic-speaking patients, which limits their clinical use. The study aims to validate these PROM instruments and explore the prevalence and severity of patient concerns related to their demographics and clinical characteristics. This observational study involves Arabic-speaking adults aged 18 and older who are planned to receive, currently receiving, or have already received radiotherapy for head and neck cancer. Participants will complete six different survey tools before, during, and after radiotherapy to assess symptoms such as dry mouth, oral mucositis, fatigue, and other concerns. Participants will be asked to complete questionnaires at multiple time points over 24 months. Researchers will collect and analyze patient-reported data using tools like the Summated Xerostomia Inventory, Patient-Reported Oral Mucositis Symptom scale, and others. The study will help clinicians better understand patient experiences and outcomes during and after radiotherapy.
CONDITIONS
Arabic PRO Measures for Head and Neck Cancer Radiotherapy.
You may qualify if you...
You will not qualify if you...
Complete this quick 3-step screening to check your eligibility
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Up to 24 months
Participants who undergo radiotherapy for head and neck cancer are observed and complete questionnaires about their symptoms and concerns.
Periodic questionnaire assessments during and after radiotherapy
Total: 1 location
1
King Saud University Medical City
Riyadh, Saudi Arabia
Actively Recruiting
A
Abdullah M Alsoghier, PhD
S
Saif A Aljabab, DABR
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Have more questions? Get in touch with our team for quick support
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Maria L Aguilar, Pamela Sandow, John W Werning...
https://pubmed.ncbi.nlm.nih.gov/28220985Turki Y Alhazzazi, Faisal T Alghamdi
https://pubmed.ncbi.nlm.nih.gov/27644659Saleh Alqaryan, Turki Aldrees, Sharif Almatrafi...
https://pubmed.ncbi.nlm.nih.gov/32291427Ann M Berger, Amy Pickar Abernethy, Ashley Atkinson...
https://pubmed.ncbi.nlm.nih.gov/20870636Nick Black
https://pubmed.ncbi.nlm.nih.gov/23358487Gianluca Catania, Carol Bell, Simona Ottonelli...
https://pubmed.ncbi.nlm.nih.gov/22790224Felipe M Cruz, Bruna A Munhoz, Beatriz Ca Alves...
https://pubmed.ncbi.nlm.nih.gov/25852820Piet Dirix, Sandra Nuyts, Walter Van den Bogaert
https://pubmed.ncbi.nlm.nih.gov/17078052Sarah Nicole Hamilton, Eric Tran, Cheryl Ho...
https://pubmed.ncbi.nlm.nih.gov/32949298Anastasios Kanatas, Derek Lowe, Simon N Rogers
https://pubmed.ncbi.nlm.nih.gov/35178880